NephrologyOnline.net

Nephrology Xagena

Search results for "End-stage renal disease"

Researchers at Mayo Clinic searching for explanations of high mortality rates among kidney failure patients undergoing hemodialysis are focusing their attention on the use of Heparin, a drug used to r ...


Patients with type 1 diabetes have an improved prognosis with regard to end-stage renal disease over the past four decades, and it appears the incidence of end-stage renal disease is lower than previo ...


Night-time hemodialysis patients may have a greater capacity to repair their hearts and blood vessels compared to those on conventional dialysis three times a week, according to a study in the America ...


Researchers at the University of California, San Francisco ( UCSF ) have determined that there is a strong relationship between being obese and developing end-stage renal disease, or kidney failure. ...


Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, accord ...


Treatment with Rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a study published in the Clinical Journal of the ...


Combination therapy with angiotensin-converting–enzyme ( ACE ) inhibitors and angiotensin-receptor blockers ( ARBs, sartans ) decreases proteinuria; however, its safety and effect on the progression o ...


Membranous nephropathy leads to end-stage renal disease in more than 20% of patients. Although immunosuppressive therapy benefits some patients, trial evidence for the subset of patients with declinin ...


The role of hyperuricemia in disease progression of autosomal dominant polycystic kidney disease ( ADPKD ) has not been defined well. Researchers have investigated the association of serum uric acid ...


In autosomal dominant polycystic kidney disease ( ADPKD ), progressive kidney cyst formation commonly leads to end-stage renal disease ( ESRD ). Because important manifestations of ADPKD may be evid ...


Risk of end-stage renal disease ( ESRD ) in kidney donors has been compared with risk faced by the general population, but the general population represents an unscreened, high-risk comparator. A co ...


Endothelial dysfunction underlies multiple cardiovascular consequences of chronic kidney disease ( CKD ) and antecedent diabetes or hypertension. Endothelial insults in chronic kidney disease or end-s ...


Edoxaban ( Lixiana, Savaysa ) is an oral, direct, once-daily, factor Xa inhibitor developed for stroke prevention in patients with atrial fibrillation and for the treatment and secondary prevention of ...


It is known that many medical adverse events can be caused by nonsteroidal anti-inflammatory drugs ( NSAIDs ); however, epidemiologic evidence has not granted an affirmative relationship between NSAID ...


Pulmonary arterial hypertension ( PAH ) is a major complication in renal failure patients, but very little information is available on the cardiovascular parameters in these patients. The prevalence ...